TY  - JOUR

T1  - Evaluating and validating immune effector dysfunction as a biomarker in bladder cancer.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2026.44.16_suppl.e16601

PY  - 2026/05/27

AU  - Safa H

AU  - Pourebrahim R

AU  - Anurag M

AU  - Holt MV

AU  - Yen AE

AU  - Lerner SP

AU  - Rutella S

AU  - Luznik L

ED  - 

DO  - DOI: 10.1200/jco.2026.44.16_suppl.e16601

PB  - American Society of Clinical Oncology (ASCO)

VL  - 44

IS  - 16_suppl

Y2  - 2026/06/21

ER  -